Derk-Jan A de Groot

9PUBLICATIONS
91CO-AUTHORS
Molecular targetsMedical physicsPredictive and prognostic markersExercise physiologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 10, 2026
Programmed death ligand 1 (PD-L1) PET/CT imaging to evaluate tumour saturation during atezolizumab treatment.

|May 08, 2026
Tri-specific Humabody CB307 Targeting CD137, Prostate-specific Membrane Antigen, and Human Serum Albumin Whole-body Biodistribution Measured with 89Zr-CB307 PET.

|Nov 10, 2025
Early [18F]FDG PET/CT Response after a Single Dose of Anti-EGFR Therapy as a Predictive Biomarker for Treatment Benefit in Patients with Advanced Colorectal Cancer.

Sophie L Gerritse, Erik J van Helden, Anne I J Arens

|Jul 10, 2025
Impact of Physical Activity on Metastatic Cancer at Diagnosis and Mortality: Results from the Lifelines Cohort Study.

Mylena D Bos, Grigory Sidorenkov, Petra C Vinke

|Mar 17, 2025
A Phase I Dose Escalation and Cohort Expansion Study of CB307, a Trispecific Humabody against PSMA, CD137, and Albumin in Patients with PSMA-Positive Solid Tumors.

Johann S de Bono, Anja Williams, Ignacio Melero

|Sep 26, 2024
Molecular imaging supports the development of multispecific cancer antibodies.

Claudia A J van Winkel, Frank R Pierik, Adrienne H Brouwers

Pageof 2

Frequent Collaborators

6 joint publications

Elisabeth Ge de Vries

4 joint publications

Adrienne H Brouwers

3 joint publications

Marjolijn N Lub-de Hooge

2 joint publications

Claudia Aj van Winkel